| 
                    world doctors
                 | 
        
            | Bile duct cancer risk may be reduced with aspirin use | 
        
            |  | 
        
            |   | 
        
            |  | 
        
            |  | 
                    The greatest international website of world doctors: |  | 
        
            |  | Bile duct cancer, also known as cholangiocarcinoma, is a cancer that begins in the bile ducts. |  | 
        
            |  | Bile ducts are thin tubes that remove bile - a yellow-green fluid - from the liver and gallbladder |  | 
        
            |  | and transport it to the small intestine, where it helps with digestion. |  | 
        
            |  | There are three types of bile duct cancers: intrahepatic, perihilar, and distal. Perihilar bile duct |  | 
        
            |  | cancer begins in the hilum - where the left and right hepatic bile ducts join - while distal bile |  | 
        
            |  | duct cancer develops further down the small intestine. |  | 
        
            |  | According to the American Cancer Society, bile duct cancer is uncommon relative to other |  | 
        
            |  | cancers, affecting around 2,000-3,000 people in the United States every year. |  | 
        
            |  | However, survival rates for bile duct cancer are low; the 5-year relative survival rate for |  | 
        
            |  | people diagnosed with intrahepatic bile duct cancer is only 15 percent, while the 5-year |  | 
        
            |  | survival rate stands at 30 percent for those diagnosed with perihilar or distal bile duct |  | 
        
            |  | cancers. |  | 
        
            |  | Now, new research - recently published in the journal Hepatology - suggests aspirin use |  | 
        
            |  | may reduce the likelihood of developing bile duct cancer. |  | 
        
            |  |  |  | 
        
            |  |  |  | 
        
            |  |  |  | 
        
            |  |  |  | 
        
            |  |  |  | 
        
            |  |  |  | 
        
            |  |  |  | 
        
            |  |  |  | 
        
            |  |  |  | 
        
            |  | 
        
            |  | 
        
            |  | 
        
            |  | 
        
            |  | 
        
            |  | 
        
            |  | 
        
            |  | 
        
            |  | 
        
            | 
 
 
 
 
 |